Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Simple blood test may be accurate in differentiating between Parkinson's disease and APDs

A simple blood test may be as accurate as a spinal fluid test when trying to determine whether symptoms are caused by Parkinson's disease or another atypical parkinsonism disorder, according to a new study published in the February 8, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

9 Feb 2017

Study finds moderate or severe signs of depression and anxiety among hospice caregivers

Currently, more than 34 million people in the U.S. care for terminally ill love ones, but few resources are available to help them navigate the challenges they encounter.

8 Feb 2017

Designer compound may be effective tool for tackling tau-related disorders

In a study of mice and monkeys, National Institutes of Health funded researchers showed that they could prevent and reverse some of the brain injury caused by the toxic form of a protein called tau.

8 Feb 2017

$Men with hip fractures experience greater cognitive impairment and higher risk of death, study shows$

Men with hip fractures experience greater cognitive impairment and higher risk of death, study shows

In a study of hip fracture patients, men displayed greater levels of cognitive impairment within the first 22 days of fracture than women, and cognitive limitations increased the risk of dying within six months in both men and women.

8 Feb 2017

Exposure to heightened air pollution increases risk of Type 2 diabetes in obese Latino children

Latino children who live in areas with higher levels of air pollution have a heightened risk of developing Type 2 diabetes, according to a new USC-led study.

7 Feb 2017

Neuroscientists clarify role of controversial immune system protein in Alzheimer's disease

Leading neuroscientists have clarified the role of a controversial immune system protein in Alzheimer's disease, showing it has opposing effects in early and late stages of the disease.

7 Feb 2017

PERK protein could be target for development of new drugs for progressive supranuclear palsy

The brain disease "progressive supranuclear palsy" (PSP) is currently incurable and its symptoms can only be eased to a very limited degree. PSP impairs eye movements, locomotion, balance control, and speech.

6 Feb 2017

Regular intake of grapes may protect against early memory decline linked to Alzheimer's disease

Consuming grapes twice a day for six months protected against significant metabolic decline in Alzheimer-related areas of the brain in a study of people with early memory decline.

3 Feb 2017

Study provides insights into functions of astrocytes following brain injury or disease

Astrocytes have long been implicated in the pathology of a range of human neurodegenerative diseases or injuries including Alzheimer's, Huntington's Parkinson's disease, brain trauma and spinal cord injury.

3 Feb 2017

Sleep helps recalibrate brain cells responsible for learning and memory, mice study shows

Studying mice, scientists at Johns Hopkins have fortified evidence that a key purpose of sleep is to recalibrate the brain cells responsible for learning and memory so the animals can "solidify" lessons learned and use them when they awaken -- in the case of nocturnal mice, the next evening.

3 Feb 2017

Single Molecule Detection of Proteins in Single Cells

We developed this technology almost 10 years ago. It was developed after a key experiment was carried out by David Rissin, who was a PhD candidate in my laboratory at the time.

From Pittcon 3 Feb 2017

Researchers develop cell culture model that could help develop early treatment strategies for AMD

An international team from the University of Alabama at Birmingham and University College London and Queens University Belfast in the United Kingdom developed a cell culture model that could help to develop earlier treatment strategies for age-related macular degeneration, the third most prevalent cause of vision loss worldwide.

3 Feb 2017

Vasculature in mini-brains expands research potential

Scientists have recently made a wondrous variety of mini-brains -- 3-D cultures of neural cells that model basic properties of living brains -- but a new finding could add to the field's growing excitement in an entirely new "vein": Brown University's mini-brains now grow blood vessels, too.

3 Feb 2017

Glucose deprivation in the brain triggers onset of cognitive decline, research shows

One of the earliest signs of Alzheimer's disease is a decline in glucose levels in the brain. It appears in the early stages of mild cognitive impairment -- before symptoms of memory problems begin to surface.

31 Jan 2017

Air pollution may greatly increase chance of dementia in older women

Tiny air pollution particles -- the type that mainly comes from power plants and automobiles -- may greatly increase the chance of dementia, including Alzheimer's disease, according to USC-led research.

31 Jan 2017

Mentally stimulating activities may decrease risk of developing mild cognitive impairment, study finds

Mayo Clinic researchers have found that engaging in mentally stimulating activities, even late in life, may protect against new-onset mild cognitive impairment, which is the intermediate stage between normal cognitive aging and dementia.

30 Jan 2017

ADT for treating advanced prostate cancer not linked to increased risk of Alzheimer disease

A large-scale, population based study led by Dr. Laurent Azoulay, Senior Investigator with the Lady Davis Institute at the Jewish General Hospital, has concluded that the use of androgen deprivation therapy (ADT) to treat advanced prostate cancer is not associated with an increased risk of Alzheimer disease.

27 Jan 2017

Alzheimer's Disease News and Research

Further Reading

Simple blood test may be accurate in differentiating between Parkinson's disease and APDs

Study finds moderate or severe signs of depression and anxiety among hospice caregivers

Designer compound may be effective tool for tackling tau-related disorders

Men with hip fractures experience greater cognitive impairment and higher risk of death, study shows

Exposure to heightened air pollution increases risk of Type 2 diabetes in obese Latino children

Neuroscientists clarify role of controversial immune system protein in Alzheimer's disease

PERK protein could be target for development of new drugs for progressive supranuclear palsy

Regular intake of grapes may protect against early memory decline linked to Alzheimer's disease

Study provides insights into functions of astrocytes following brain injury or disease

Sleep helps recalibrate brain cells responsible for learning and memory, mice study shows

Single Molecule Detection of Proteins in Single Cells

Researchers develop cell culture model that could help develop early treatment strategies for AMD

Vasculature in mini-brains expands research potential

Glucose deprivation in the brain triggers onset of cognitive decline, research shows

Air pollution may greatly increase chance of dementia in older women

Mentally stimulating activities may decrease risk of developing mild cognitive impairment, study finds

ADT for treating advanced prostate cancer not linked to increased risk of Alzheimer disease

Marginal deficiency of vitamin A in fetus or newborns may lead to Alzheimer's disease in later life

Brain shape can provide surprising clues to personality differences, FSU research reveals

Synthetic molecule appears to reverse Alzheimer's-related neurological damage

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News